Vision Loss, Damage Could Be Tied to Eye Pressure, Study Finds Findings could offer earlier warning signs for those at risk of glaucoma

A new study published in Cell Reports Medicine has found that a vitamin supplement designed to improve metabolism in the eye may help slow down damage to the optic nerve in people with glaucoma. These promising findings have led researchers at Karolinska Institutet to begin a clinical trial to test the treatment on patients.

Advancements like SLT (selective laser trabeculoplasty) have reshaped glaucoma treatment, improving patient outcomes compared to those treated with eye drops. In the eyes of many, it's a five-minute procedure that can help preserve vision and prevent blindness in the long run.

Glaucoma is a complex eye condition that damages the optic nerve over time. If untreated, the disease can cause permanent vision loss and lead to blindness. Glaucoma, which affects more than 4 million Americans, is characterized by elevated pressure within the eye (known as intraocular pressure or IOP).